Clinical trial
Efficacy & Long-term Safety Comparison Study of NK-104-CR & Livalo® IR With Primary Hyperlipidemia or Mixed Dyslipidemia
NCT02799758 is registered in ClinicalTrials.gov with Kowa Research Institute, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy & Long-term Safety Comparison Study of NK-104-CR & Livalo® IR With Primary Hyperlipidemia or Mixed Dyslipidemia
- Lead sponsor
- Kowa Research Institute, Inc.
- Phase
- Phase 3
- Overall status
- Withdrawn
- Start date
- February 29, 2016
- Completion date
- November 30, 2017
- Enrollment
- 0 (actual)
- Sites
- 69
Conditions
As the registry lists them; a condition with its own page is linked.
dyslipidemia, hyperlipidemia